TTV-GUIDE

The TTV GUIDE TX project is a Horizon 2020-funded initiative dedicated to enhancing kidney transplant outcomes through personalized immunosuppressive therapies. By utilizing Torque Teno Virus (TTV) levels as biomarkers, we aim to tailor immunosuppression to each patient's unique needs, minimizing risks of rejection and infection. Our consortium comprises leading experts in nephrology, virology, and clinical research, collaborating to revolutionize post-transplant care. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No [896932]. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.